HCMT
UROV

Highland Capital Management (Texas)’s Urovant Sciences Ltd. UROV Stock Holding History

Highland Capital Management (Texas)’s Portfolio UROV Stock Details UROV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-30,000
Closed -$198K – 354
2018
Q4 		$198K Sell
30,000
-28,100
-48% -$256K 0.02% 251
2018
Q3 		$697K Buy
+58,100
New +$687K 0.04% 197

Other funds holding UROV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Highland Capital Management (Texas)'s UROV Position: Q1 2019 in Review

Highland Capital Management (Texas) sold out of Urovant Sciences Ltd. (UROV) in Q1 2019, closing a stake of 30,000 shares — an estimated $198K sold.

Highland Capital Management (Texas) first reported a position in UROV in Q3 2018 and held it in 2 quarters. The position peaked at $697K in Q3 2018. 21 funds tracked by Wall St. Rank hold UROV as of Q1 2019.

  • Highland Capital Management (Texas) reported no remaining Urovant Sciences Ltd. position as of Q1 2019 after selling out during the quarter.
  • Highland Capital Management (Texas) sold 30,000 Urovant Sciences Ltd. shares in Q1 2019, an estimated $198K.
  • Highland Capital Management (Texas) first reported a position in Urovant Sciences Ltd. in Q3 2018 and held it in 2 quarters.
  • Highland Capital Management (Texas)'s Urovant Sciences Ltd. position peaked at $697K in Q3 2018.
  • 21 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q1 2019.

Based on Highland Capital Management (Texas)'s 13F filing for Q1 2019, filed 15 May 2019.